| 摘要 |
Multilayer tablets of a proton pump inhibitor essentially bioequivalent in terms of plasma Cmax and AUC to capsules and/or tablets consisting of multiple unit pellets of the proton pump inhibitor are provided. Also provided are methods for production of these multilayer tablets and methods for their use in treating dyspepsia, peptic ulcer disease, gastroesophageal reflux disease and Zollinger-Ellison syndrome. |
